Shopping Cart 0
Cart Subtotal
AED 0

Global Circular Tumor Cell (CTC) Diagnostics Market (By Technology - CTC Enrichment, CTC Detection and CTC Diagnosis; By Application - Breast Cancer, Lung Cancer, ColoRectal Cancer, Prostrate Cancer and Others, By End-User- Biotechnological Research Centers, Hospitals & Clinics, Pharmaceuticals, Academic Research Institutions) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 17598

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 24938

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 28608

Details

The report covers the analysis and forecast of the circulating tumor cell (CTC) diagnostics market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (USD Bn).

The study provides a detailed view of the circulating tumor cell (CTC) diagnostics market, by segmenting it based on, technology, application, end-user and regional demand. The technology segment includes CTC enrichment, CTC detection and CTC analysis. The CTC enrichment section can be sub segmented into microchips, single spiral micro channel, positive (both in-vivo and ex-vivo types) and negative selection; while on the other hand, CTC detection procedure consists of molecular-based (RNA) technologies, optical-based flow cytometry, EPISPOT in-vitro cell culture, in-vitro cell invasion assay and different xenotransplantation models.

Based on application, the market can be classified into different kinds of cancer viz. breast cancer, lung cancer, colorectal cancer, prostate cancer and others (skin cancer, pancreatic cancer and ovarian cancer).

End-User segment includes biotechnological research centers, hospitals and clinics, pharmaceuticals and academic research institutions.

Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Market dynamics for each region has been provided in the report.

READ MORE

Table Of Content

Scope

1 INTRODUCTION

1.1 MARKET SEGMENTATION

2 RESEARCH METHODOLOGY

2.1 ECOSYSTEM OF MARKET

2.2 TOP-DOWN APPROACH

2.3 BOTTOM-UP APPROACH

2.4 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET SNAPSHOT

3.2 GLOBAL CTC DIAGNOSTICS MARKET REVENUE, 2017-2025 (USD BN)

4 MARKET OVERVIEW

4.1 INTRODUCTION

4.2 KEY TRENDS ANALYSIS

4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS

4.4 PORTERS FIVE FORCE ANALYSIS

4.5 VALUE CHAIN ANALYSIS

4.6 COMPETITIVE LANDSCAPE

4.7 COMPANY MARKET SHARE ANALYSIS, %, 2016

4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS

5 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET, BY TECHNOLOGY

5.1 OVERVIEW

5.2 GLOBAL CTC DIAGNOSTICS MARKET FOR CTC (TUMOR) ENRICHMENT, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

5.3 GLOBAL CTC DIAGNOSTICS MARKET FOR CTC (TUMOR) DETECTION, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

5.4 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR CTC ANALYSIS; VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

6 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET, BY APPLICATION

6.1 OVERVIEW

6.2 GLOBAL CTC DIAGNOSTICS MARKET FOR BREAST CANCER, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

6.3 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR LUNG CANCER, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

6.4 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR COLORECTAL CANCER, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

6.5 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR PROSTATE CANCER, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

6.6 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR OTHERS (SKIN CANCER, PANCREATICCANCER & OVARIAN CANCER) CANCER, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

7 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET, BY END-USER

7.1 OVERVIEW

7.2 GLOBAL CTC DIAGNOSTICS MARKET FOR BIOTECHNOLOGICAL RESEARCH CENTERS, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

7.3 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR , HOSPITALS & CLINICS, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

7.4 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR PHARMACEUTICALS , VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

7.5 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR, ACADEMIC RESEARCH INSTITUTIONS , VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

8 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET, BY GEOGRAPHY

8.1 NORTH AMERICA

8.1.1 MARKET DYNAMICS

8.1.1.1 Drivers

8.1.1.2 Restraints

8.1.1.3 Opportunity

8.1.2 U.S.

8.1.3 CANADA

8.1.4 MEXICO

8.2 EUROPE

8.2.1 MARKET DYNAMICS

8.2.1.1 Drivers

8.2.1.2 Restraints

8.2.1.3 Opportunity

8.2.2 U.K.

8.2.3 ITALY

8.2.4 FRANCE

8.2.5 GERMANY

8.2.6 RUSSIA

8.2.7 SPAIN

8.2.8 REST OF EUROPE

8.3 ASIA PACIFIC

8.3.1 MARKET DYNAMICS

8.3.1.1 Drivers

8.3.1.2 Restraints

8.3.1.3 Opportunity

8.3.2 INDIA

8.3.3 CHINA

8.3.4 JAPAN

8.3.5 AUSTRALIA

8.3.6 REST OF ASIA PACIFIC

8.4 MIDDLE EAST AND AFRICA

8.4.1 MARKET DYNAMICS

8.4.1.1 Drivers

8.4.1.2 Restraints

8.4.1.3 Opportunity

8.4.2 GCC

8.4.3 SOUTH AFRICA

8.4.4 REST OF MIDDLE EAST AND AFRICA

8.5 LATIN AMERICA

8.5.1 MARKET DYNAMICS

8.5.1.1 Drivers

8.5.1.2 Restraints

8.5.1.3 Opportunity

8.5.2 BRAZIL

8.5.3 REST OF LATIN AMERICA

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW

9.2 NEW PRODUCT LAUNCHES

10 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET, BY COMPANY

10.1 INTRODUCTION

10.2 ADNAGEN AG

10.2.1 BUSINESS OVERVIEW

10.2.2 PRODUCTS & SERVICES

10.2.3 KEY STRATEGY

10.2.4 RECENT DEVELOPMENTS

10.2.5 SWOT ANALYSIS

10.2.6 OUR COMPANY VIEW

10.3 ADVANCED CELL DIAGNOSTICS

10.3.1 BUSINESS OVERVIEW

10.3.2 PRODUCTS & SERVICES

10.3.3 KEY STRATEGY

10.3.4 RECENT DEVELOPMENTS

10.3.5 SWOT ANALYSIS

10.3.6 OUR COMPANY VIEW

10.4 AVIVA BIOSCIENCES CORP.

10.4.1 BUSINESS OVERVIEW

10.4.2 PRODUCTS & SERVICES

10.4.3 KEY STRATEGY

10.4.4 RECENT DEVELOPMENTS

10.4.5 SWOT ANALYSIS

10.4.6 OUR COMPANY VIEW

10.5 BIOCEPT, INC.

10.5.1 BUSINESS OVERVIEW

10.5.2 PRODUCTS & SERVICES

10.5.3 KEY STRATEGY

10.5.4 RECENT DEVELOPMENTS

10.5.5 SWOT ANALYSIS

10.5.6 OUR COMPANY VIEW

10.6 CELULA, INC.

10.6.1 BUSINESS OVERVIEW

10.6.2 PRODUCTS & SERVICES

10.6.3 KEY STRATEGY

10.6.4 RECENT DEVELOPMENTS

10.6.5 SWOT ANALYSIS

10.6.6 OUR COMPANY VIEW

10.7 CYNVENIO BIOSYSTEMS, INC.

10.7.1 BUSINESS OVERVIEW

10.7.2 PRODUCTS & SERVICES

10.7.3 KEY STRATEGY

10.7.4 RECENT DEVELOPMENTS

10.7.5 SWOT ANALYSIS

10.7.6 OUR COMPANY VIEW

10.8 EPIC SCIENCES, INC.

10.8.1 BUSINESS OVERVIEW

10.8.2 PRODUCTS & SERVICES

10.8.3 KEY STRATEGY

10.8.4 RECENT DEVELOPMENTS

10.8.5 SWOT ANALYSIS

10.8.6 OUR COMPANY VIEW

10.9 FLUXION BIOSCIENCES, INC.

10.9.1 BUSINESS OVERVIEW

10.9.2 PRODUCTS & SERVICES

10.9.3 KEY STRATEGY

10.9.4 RECENT DEVELOPMENTS

10.9.5 SWOT ANALYSIS

10.9.6 OUR COMPANY VIEW

10.10 MENARINI SILICON BIOSYSTEMS, INC.

10.10.1 BUSINESS OVERVIEW

10.10.2 PRODUCTS & SERVICES

10.10.3 KEY STRATEGY

10.10.4 RECENT DEVELOPMENTS

10.10.5 SWOT ANALYSIS

10.10.6 OUR COMPANY VIEW

10.11 NANOSTRING TECHNOLOGIES, INC.

10.11.1 BUSINESS OVERVIEW

10.11.2 PRODUCTS & SERVICES

10.11.3 KEY STRATEGY

10.11.4 RECENT DEVELOPMENTS

10.11.5 SWOT ANALYSIS

10.11.6 OUR COMPANY VIEW

10.12 RARECELLS, USA

10.12.1 BUSINESS OVERVIEW

10.12.2 PRODUCTS & SERVICES

10.12.3 KEY STRATEGY

10.12.4 RECENT DEVELOPMENTS

10.12.5 SWOT ANALYSIS

10.12.6 OUR COMPANY VIEW

10.13 VERIDEX , LLC.

10.13.1 BUSINESS OVERVIEW

10.13.2 PRODUCTS & SERVICES

10.13.3 KEY STRATEGY

10.13.4 RECENT DEVELOPMENTS

10.13.5 SWOT ANALYSIS

10.13.6 OUR COMPANY VIEW

10.14 VITATEX INC.

10.14.1 BUSINESS OVERVIEW

10.14.2 PRODUCTS & SERVICES

10.14.3 KEY STRATEGY

10.14.4 RECENT DEVELOPMENTS

10.14.5 SWOT ANALYSIS

10.14.6 OUR COMPANY VIEW

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The report covers the analysis and forecast of the circulating tumor cell (CTC) diagnostics market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (USD Bn).

The study provides a detailed view of the circulating tumor cell (CTC) diagnostics market, by segmenting it based on, technology, application, end-user and regional demand. The technology segment includes CTC enrichment, CTC detection and CTC analysis. The CTC enrichment section can be sub segmented into microchips, single spiral micro channel, positive (both in-vivo and ex-vivo types) and negative selection; while on the other hand, CTC detection procedure consists of molecular-based (RNA) technologies, optical-based flow cytometry, EPISPOT in-vitro cell culture, in-vitro cell invasion assay and different xenotransplantation models.

Based on application, the market can be classified into different kinds of cancer viz. breast cancer, lung cancer, colorectal cancer, prostate cancer and others (skin cancer, pancreatic cancer and ovarian cancer).

End-User segment includes biotechnological research centers, hospitals and clinics, pharmaceuticals and academic research institutions.

Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Market dynamics for each region has been provided in the report.

READ MORE

Scope

1 INTRODUCTION

1.1 MARKET SEGMENTATION

2 RESEARCH METHODOLOGY

2.1 ECOSYSTEM OF MARKET

2.2 TOP-DOWN APPROACH

2.3 BOTTOM-UP APPROACH

2.4 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET SNAPSHOT

3.2 GLOBAL CTC DIAGNOSTICS MARKET REVENUE, 2017-2025 (USD BN)

4 MARKET OVERVIEW

4.1 INTRODUCTION

4.2 KEY TRENDS ANALYSIS

4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS

4.4 PORTERS FIVE FORCE ANALYSIS

4.5 VALUE CHAIN ANALYSIS

4.6 COMPETITIVE LANDSCAPE

4.7 COMPANY MARKET SHARE ANALYSIS, %, 2016

4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS

5 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET, BY TECHNOLOGY

5.1 OVERVIEW

5.2 GLOBAL CTC DIAGNOSTICS MARKET FOR CTC (TUMOR) ENRICHMENT, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

5.3 GLOBAL CTC DIAGNOSTICS MARKET FOR CTC (TUMOR) DETECTION, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

5.4 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR CTC ANALYSIS; VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

6 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET, BY APPLICATION

6.1 OVERVIEW

6.2 GLOBAL CTC DIAGNOSTICS MARKET FOR BREAST CANCER, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

6.3 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR LUNG CANCER, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

6.4 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR COLORECTAL CANCER, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

6.5 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR PROSTATE CANCER, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

6.6 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR OTHERS (SKIN CANCER, PANCREATICCANCER & OVARIAN CANCER) CANCER, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

7 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET, BY END-USER

7.1 OVERVIEW

7.2 GLOBAL CTC DIAGNOSTICS MARKET FOR BIOTECHNOLOGICAL RESEARCH CENTERS, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

7.3 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR , HOSPITALS & CLINICS, VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

7.4 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR PHARMACEUTICALS , VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

7.5 GLOBAL GLOBAL CTC DIAGNOSTICS MARKET FOR, ACADEMIC RESEARCH INSTITUTIONS , VOLUME & REVENUE, 2017-2025, (UNITS) (USD BN)

8 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET, BY GEOGRAPHY

8.1 NORTH AMERICA

8.1.1 MARKET DYNAMICS

8.1.1.1 Drivers

8.1.1.2 Restraints

8.1.1.3 Opportunity

8.1.2 U.S.

8.1.3 CANADA

8.1.4 MEXICO

8.2 EUROPE

8.2.1 MARKET DYNAMICS

8.2.1.1 Drivers

8.2.1.2 Restraints

8.2.1.3 Opportunity

8.2.2 U.K.

8.2.3 ITALY

8.2.4 FRANCE

8.2.5 GERMANY

8.2.6 RUSSIA

8.2.7 SPAIN

8.2.8 REST OF EUROPE

8.3 ASIA PACIFIC

8.3.1 MARKET DYNAMICS

8.3.1.1 Drivers

8.3.1.2 Restraints

8.3.1.3 Opportunity

8.3.2 INDIA

8.3.3 CHINA

8.3.4 JAPAN

8.3.5 AUSTRALIA

8.3.6 REST OF ASIA PACIFIC

8.4 MIDDLE EAST AND AFRICA

8.4.1 MARKET DYNAMICS

8.4.1.1 Drivers

8.4.1.2 Restraints

8.4.1.3 Opportunity

8.4.2 GCC

8.4.3 SOUTH AFRICA

8.4.4 REST OF MIDDLE EAST AND AFRICA

8.5 LATIN AMERICA

8.5.1 MARKET DYNAMICS

8.5.1.1 Drivers

8.5.1.2 Restraints

8.5.1.3 Opportunity

8.5.2 BRAZIL

8.5.3 REST OF LATIN AMERICA

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW

9.2 NEW PRODUCT LAUNCHES

10 GLOBAL CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS MARKET, BY COMPANY

10.1 INTRODUCTION

10.2 ADNAGEN AG

10.2.1 BUSINESS OVERVIEW

10.2.2 PRODUCTS & SERVICES

10.2.3 KEY STRATEGY

10.2.4 RECENT DEVELOPMENTS

10.2.5 SWOT ANALYSIS

10.2.6 OUR COMPANY VIEW

10.3 ADVANCED CELL DIAGNOSTICS

10.3.1 BUSINESS OVERVIEW

10.3.2 PRODUCTS & SERVICES

10.3.3 KEY STRATEGY

10.3.4 RECENT DEVELOPMENTS

10.3.5 SWOT ANALYSIS

10.3.6 OUR COMPANY VIEW

10.4 AVIVA BIOSCIENCES CORP.

10.4.1 BUSINESS OVERVIEW

10.4.2 PRODUCTS & SERVICES

10.4.3 KEY STRATEGY

10.4.4 RECENT DEVELOPMENTS

10.4.5 SWOT ANALYSIS

10.4.6 OUR COMPANY VIEW

10.5 BIOCEPT, INC.

10.5.1 BUSINESS OVERVIEW

10.5.2 PRODUCTS & SERVICES

10.5.3 KEY STRATEGY

10.5.4 RECENT DEVELOPMENTS

10.5.5 SWOT ANALYSIS

10.5.6 OUR COMPANY VIEW

10.6 CELULA, INC.

10.6.1 BUSINESS OVERVIEW

10.6.2 PRODUCTS & SERVICES

10.6.3 KEY STRATEGY

10.6.4 RECENT DEVELOPMENTS

10.6.5 SWOT ANALYSIS

10.6.6 OUR COMPANY VIEW

10.7 CYNVENIO BIOSYSTEMS, INC.

10.7.1 BUSINESS OVERVIEW

10.7.2 PRODUCTS & SERVICES

10.7.3 KEY STRATEGY

10.7.4 RECENT DEVELOPMENTS

10.7.5 SWOT ANALYSIS

10.7.6 OUR COMPANY VIEW

10.8 EPIC SCIENCES, INC.

10.8.1 BUSINESS OVERVIEW

10.8.2 PRODUCTS & SERVICES

10.8.3 KEY STRATEGY

10.8.4 RECENT DEVELOPMENTS

10.8.5 SWOT ANALYSIS

10.8.6 OUR COMPANY VIEW

10.9 FLUXION BIOSCIENCES, INC.

10.9.1 BUSINESS OVERVIEW

10.9.2 PRODUCTS & SERVICES

10.9.3 KEY STRATEGY

10.9.4 RECENT DEVELOPMENTS

10.9.5 SWOT ANALYSIS

10.9.6 OUR COMPANY VIEW

10.10 MENARINI SILICON BIOSYSTEMS, INC.

10.10.1 BUSINESS OVERVIEW

10.10.2 PRODUCTS & SERVICES

10.10.3 KEY STRATEGY

10.10.4 RECENT DEVELOPMENTS

10.10.5 SWOT ANALYSIS

10.10.6 OUR COMPANY VIEW

10.11 NANOSTRING TECHNOLOGIES, INC.

10.11.1 BUSINESS OVERVIEW

10.11.2 PRODUCTS & SERVICES

10.11.3 KEY STRATEGY

10.11.4 RECENT DEVELOPMENTS

10.11.5 SWOT ANALYSIS

10.11.6 OUR COMPANY VIEW

10.12 RARECELLS, USA

10.12.1 BUSINESS OVERVIEW

10.12.2 PRODUCTS & SERVICES

10.12.3 KEY STRATEGY

10.12.4 RECENT DEVELOPMENTS

10.12.5 SWOT ANALYSIS

10.12.6 OUR COMPANY VIEW

10.13 VERIDEX , LLC.

10.13.1 BUSINESS OVERVIEW

10.13.2 PRODUCTS & SERVICES

10.13.3 KEY STRATEGY

10.13.4 RECENT DEVELOPMENTS

10.13.5 SWOT ANALYSIS

10.13.6 OUR COMPANY VIEW

10.14 VITATEX INC.

10.14.1 BUSINESS OVERVIEW

10.14.2 PRODUCTS & SERVICES

10.14.3 KEY STRATEGY

10.14.4 RECENT DEVELOPMENTS

10.14.5 SWOT ANALYSIS

10.14.6 OUR COMPANY VIEW

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS